Fu, J.; Yu, S.; Zhao, X.; Zhang, C.; Shen, L.; Liu, Y.; Yu, H.
Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux. Int. J. Mol. Sci. 2022, 23, 16034.
https://doi.org/10.3390/ijms232416034
AMA Style
Fu J, Yu S, Zhao X, Zhang C, Shen L, Liu Y, Yu H.
Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux. International Journal of Molecular Sciences. 2022; 23(24):16034.
https://doi.org/10.3390/ijms232416034
Chicago/Turabian Style
Fu, Jiaying, Sihang Yu, Xiyao Zhao, Chaoke Zhang, Luyan Shen, Yanan Liu, and Huimei Yu.
2022. "Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux" International Journal of Molecular Sciences 23, no. 24: 16034.
https://doi.org/10.3390/ijms232416034
APA Style
Fu, J., Yu, S., Zhao, X., Zhang, C., Shen, L., Liu, Y., & Yu, H.
(2022). Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux. International Journal of Molecular Sciences, 23(24), 16034.
https://doi.org/10.3390/ijms232416034